kwic
group
group
right
off
ON
217
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for group out of >500 occurrences
385944 occurrences (No.46 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to group]
385944 occurrences (No.46 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 217) Also, CP group showed an increase in the immunohistochemical expression of Bax proapoptotic protein. |
| PMID:23552260 DOI:10.1177/0748233713483198 |
| 2015 Toxicology and industrial health |
| * Histological, ultrastructural and immunohistochemical studies on the protective effect of ginger extract against cisplatin-induced nephrotoxicity in male rats. |
| - Cisplatin (CP) is a widely used anticancer drug; however, it has several side effects such as nephrotoxicity. Ginger, the rhizome of Zingiber officinale, consumed since ancient times has numerous health benefits. The objective of this work was to evaluate the protective effect of ginger extract (GE) against CP-induced nephrotoxicity. CP group displayed a marked renal failure characterized by a significant increase in serum creatinine and blood urea nitrogen (BUN) levels in addition to severe histopathological and ultrastructural renal alterations. Also, CP group showed an increase in the immunohistochemical expression of Bax proapoptotic protein. In contrast, GE+CP group showed significant decrease in the elevated serum creatinine and BUN levels and an improvement in the histopathological and ultrastructural renal injury induced by CP. The overexpression of Bax proapoptotic protein was significantly decreased in the GE+CP group. Hence, the present results indicated that GE has a protective effect against CP-induced renal damage in rats. Thereby, such findings recommended the usage of GE to prevent and/or decrease the renal damage induced by CP chemotherapeutic treatment. |
[
right
kwic]
| (1)49 *null* | (15)7  received |
(29)3 II |
(44)2 difference |
| (2)33 was |
(16)5 at |
(30)3 after |
(45)2 displayed |
| (3)29 and |
(17)5 for |
(31)3 comprised |
(46)2 dynamics-based |
| (4)25 of |
(18)5 the |
(32)3 in |
(47)2 exhibited |
| (5)16 compared |
(19)5 to |
(33)3 when |
(48)2 however, |
| (6)12 A |
(20)4 (p |
(34)2 (30 |
(49)2 improved |
| (7)12 were |
(21)4 B |
(35)2 (n |
(50)2 included |
| (8)11 discussions |
(22)4 C |
(37)2 B, |
(51)2 intervention |
| (9)10 than |
(23)4 differences |
(38)2 III |
(52)2 interventions |
| (10)9 I |
(24)4 or |
(39)2 V |
(53)2 interviews |
| (11)8 had |
(25)3 1, |
(40)2 a |
(54)2 patients |
| (12)8 showed |
(26)3 2 |
(41)2 as |
(55)2 presented |
| (13)8 with |
(27)3 4 |
(42)2 contains |
(56)2 that |
| (14)7 1 |
(28)3 A, |
(43)2 demonstrated |
add keyword
--- WordNet output for group ---